Milagros Vela - Publications

Influence of vedolizumab on extraintestinal manifestations in inflammatory bowel disease: a nationwide multicenter study of the GETECCU ENEIDA Registry.

Journal: Journal of Crohn's & colitis

Published: March 26, 2026

Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry.

Journal: United European gastroenterology journal

Published: October 23, 2025

Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry.

Journal: Alimentary pharmacology & therapeutics

Published: January 09, 2024

Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: December 30, 2023

Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.

Journal: Therapeutic advances in gastroenterology

Published: June 19, 2023

Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease.

Journal: Clinical and translational gastroenterology

Published: November 01, 2021

Corrigendum to: Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.

Journal: Inflammatory bowel diseases

Published: October 12, 2021

QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease.

Journal: Journal of clinical medicine

Published: July 28, 2021

Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease.

Journal: Journal of clinical medicine

Published: June 27, 2021

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.

Journal: Journal of clinical medicine

Published: May 19, 2021

Carotid Plaque Assessment Reclassifies Patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk.

Journal: Journal of clinical medicine

Published: March 13, 2021

Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This Therapy.

Journal: Inflammatory bowel diseases

Published: December 16, 2020